Rigel Pharmaceuticals' stock gain contrasts with the performance of the Zacks Medical sector.
3 reports, 1 independent
Updated Aug 25
Gone quiet
- Reports
- 3
- Developments
- 5
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rigel Pharmaceuticals' stock gain contrasts with the performance of the Zacks Medical sector.
How it developed
Newest first. Tap a step to see who reported it.- Rigel Pharmaceuticals' stock experienced a Golden Cross on August 7, 2025.Sub-event
- Rigel Pharmaceuticals, Inc. reported that its Q2 financial results surpassed market expectations.Sub-event
- Rigel Pharmaceuticals' shares gained 61% on August 8, 2025, while APi Group and CleanSpark also posted gains against the S&P 500.Sub-event
- High accrual ratio suggests lower profit growth for Rigel Pharmaceuticals as of August 13, 2025.Sub-event
Rigel's stock gain contrasts with the broader medical sector performance.1 source
Coverage
Newest first; wire copies grouped- ZacksRigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? A strong stock as of late has been Rigel Pharmaceuticals (RIGL). Shares have been marching higher, with the stock up 105.8%
- ZacksRigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? Shares of Rigel Pharmaceuticals (RIGL) have been strong performers lately, with the stock up 56.6% over the past month.
- ZacksWhy Rigel (RIGL) Could Beat Earnings Estimates Again Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarte